Emerging Biomarkers of Response to Systemic Therapies in Metastatic Clear Cell Renal Cell Carcinoma

被引：4
|
作者：
Labaki, Chris [1 ,2 ]
Saliby, Renee Maria [1 ]
Bakouny, Ziad [1 ,3 ]
Saad, Eddy [1 ]
Semaan, Karl [1 ]
Eid, Marc [1 ]
Lalani, Aly-Khan [4 ]
Choueiri, Toni K. [1 ]
Braun, David A. [5 ]
机构：
[1] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[2] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Dept Med, Boston, MA USA
[4] McMaster Univ, Juravinski Canc Ctr, Hamilton, ON, Canada
[5] Yale Sch Med, Ctr Mol & Cellular Oncol CMCO, New Haven, CT USA
来源：
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2023年 / 37卷 / 05期
关键词：
Renal cell carcinoma; Biomarkers; Systemic therapy; Immunotherapy; Targeted therapy; MOLECULAR SUBTYPES; 1ST-LINE TREATMENT; CHECKPOINT; SUNITINIB;
D O I：
10.1016/j.hoc.2023.05.021
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：937 / 942
页数：6
相关论文
共 50 条
  • [21] The genomic landscape of metastatic clear cell renal cell carcinoma after systemic therapy
    van der Mijn, Johannes C.
    Eng, Kenneth W.
    Chandra, Pooja
    Fernandez, Evan
    Ramazanoglu, Sinan
    Sigaras, Alexandros
    Oromendia, Clara
    Gudas, Lorraine J.
    Tagawa, Scott T.
    Nanus, David M.
    Faltas, Bishoy F.
    Beltran, Himisha
    Sternberg, Cora N.
    Elemento, Olivier
    Sboner, Andrea
    Mosquera, Juan Miguel
    Molina, Ana M.
    MOLECULAR ONCOLOGY, 2022, 16 (12) : 2384 - 2395
  • [22] HIF pathway and c-Myc as biomarkers for response to sunitinib in metastatic clear-cell renal cell carcinoma
    Maroto, P.
    Esteban, E.
    Fernandez Parra, E.
    Mendez-Vidal, M. J.
    Domenech, M.
    Perez-Valderrama, B.
    Calderero, V.
    Perez-Gracia, J. L.
    Grande, E.
    Algaba, F.
    ONCOTARGETS AND THERAPY, 2017, 10 : 4635 - 4642
  • [23] Biomarkers of Prognosis and Efficacy of Anti-angiogenic Therapy in Metastatic Clear Cell Renal Cancer
    D'Aniello, Carmine
    Berretta, Massimiliano
    Cavaliere, Carla
    Rossetti, Sabrina
    Facchini, Bianca Arianna
    Iovane, Gelsomina
    Mollo, Giovanna
    Capasso, Mariagrazia
    Della Pepa, Chiara
    Pesce, Laura
    D'Errico, Davide
    Buonerba, Carlo
    Di Lorenzo, Giuseppe
    Pisconti, Salvatore
    De Vita, Ferdinando
    Facchini, Gaetano
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [24] Systemic therapy of metastatic renal cell carcinoma
    Autenrieth, M.
    Heidenreich, A.
    Gschwend, J. E.
    UROLOGE, 2006, 45 (05): : 594 - 599
  • [25] Systemic therapy of metastatic renal cell carcinoma
    Maute, Luise
    Bergmann, Lothar
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2016, 141 (07) : 466 - 469
  • [26] Systemic therapy in metastatic renal cell carcinoma
    Bedke, Jens
    Gauler, Thomas
    Gruenwald, Viktor
    Hegele, Axel
    Herrmann, Edwin
    Hinz, Stefan
    Janssen, Jan
    Schmitz, Stephan
    Schostak, Martin
    Tesch, Hans
    Zastrow, Stefan
    Miller, Kurt
    WORLD JOURNAL OF UROLOGY, 2017, 35 (02) : 179 - 188
  • [27] Systemic therapy of metastatic renal cell carcinoma
    Autenrieth M.
    Heidenreich A.
    Gschwend J.E.
    Der Urologe, 2006, 45 (5): : 594 - 599
  • [28] Update on targeted therapies for clear cell renal cell carcinoma
    Singer, Eric A.
    Gupta, Gopal N.
    Srinivasan, Ramaprasad
    CURRENT OPINION IN ONCOLOGY, 2011, 23 (03) : 283 - 289
  • [29] Biomarkers in clear cell renal cell carcinoma
    George, Saby
    Bukowski, Ronald M.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2007, 7 (12) : 1737 - 1747
  • [30] An Overview of Systemic Targeted Therapy in Renal Cell Carcinoma, with a Focus on Metastatic Renal Cell Carcinoma and Brain Metastases
    Semenescu, Liliana Eleonora
    Kamel, Amira
    Ciubotaru, Vasile
    Baez-Rodriguez, Silvia Mara
    Furtos, Mircea
    Costachi, Alexandra
    Dricu, Anica
    Tataranu, Ligia Gabriela
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2023, 45 (09) : 7680 - 7704
12345